Most people don’t like going to the doctor. That’s why Theodoros Zanos, a researcher at The Feinstein Institute for Medical Research, is working on a technology that might one day be able to listen to, and decode the body’s electrical signals, catching warning signs of illness.
Diagnostics allow for the identification of cancer types and other crucial biomarkers, and are used right through from discovery to market.
While some people are warning about artificial intelligence leading to killer robots, researchers are showing the positive impact of A.I. in its potential to overcome disease.
Much of medicine is about information — the data that helps doctors make the right choices about our treatment. So how will the revolution in big data impact complex healthcare systems like the NHS?
Geisinger Health System CEO, Dr. David Feinberg reveals health system’s pioneering precision health efforts will be recommended to every patient.
For the first time, scientists have revealed the essential genes for the most deadly human malaria parasite, Plasmodium falciparum. They have created new genomic techniques to analyse every gene in the parasite and determine which ones are indispensable.
The National Insitute of Health is finally launching All of Us, a huge research study with the aim of making precision medicine available to people of all backgrounds. But will people give up their data?
Deep learning computers in a diagnostic imaging lab routinely defeat their human counterparts in diagnosing heart failure, detecting various cancers and predicting their strength.
A new method for diagnosing breast cancer involves a pill, which could do a better job distinguishing between benign and aggressive tumours.
Researchers at the Broad Institute of MIT and Harvard have reported that their platform, SHERLOCK, now can be used to detect viruses directly in clinical samples such as blood or saliva.
Biotech startup Mammoth Biosciences launches a CRISPR powered search engine that ‘works like Google’ for disease detection.
Many conclusions drawn from a common approach to the study of human genetics could be distorted because of a previously overlooked phenomenon.
AI genomics company Freenome has announced a partnership with proteomics company Biognosys, to enhance its broad-signal approach to early-cancer detection and precision oncology.
23andMe has provided their customers with a new health portal that makes it possible to share how they manage 18 common health conditions, including depression, ADHD, migraine and asthma.
To fully benefit from the vast quantities of data from TCGA, tools for easy data visualisation and analysis must be developed for use of the non-computational scientist. Our panel of experts discuss TCGA data and the tools needed to make sense of it.